Related Experiment Video
Updated: Aug 12, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
Hepatitis B and the theatre nurse
Operating theatre staff must now declare hepatitis B status and provide proof of immunization or non-carrier status. Failure to comply means exclusion from exposure-prone procedures, impacting employment for healthcare workers.
Area of Science:
- Occupational Health
- Infectious Disease Control
- Public Health Policy
Background:
- The Department of Health (DOH) implemented a policy change affecting operating theatre staff regarding hepatitis B status.
- Staff undertaking exposure-prone procedures (EPP) are classified as EPP workers.
Purpose of the Study:
- To inform operating theatre staff about new DOH policy requirements for hepatitis B immunization and status declaration.
- To outline the implications for employment of staff who refuse immunization or are non-responders.
Main Methods:
- Policy review and dissemination of DOH guidelines.
- Requirement for staff to declare hepatitis B status, including immunization records and carrier status.
- Mandatory occupational health assessments for EPP workers.
Main Results:
- Effective July 1, 1995, all operating theatre staff must declare their hepatitis B status.
- Job applicants must provide proof of immunization; otherwise, they will not be offered a post.
- Staff refusing immunization or failing to demonstrate non-carrier status will be excluded from EPP work.
Conclusions:
- Compliance with hepatitis B immunization and status declaration is mandatory for operating theatre staff involved in EPP.
- Non-compliance can lead to exclusion from EPP duties and affect employment.
- Regular monitoring (every six months) is required for non-responders to immunization.
More Related Videos
09:27Multicellular Human Alveolar Model Composed of Epithelial Cells and Primary Immune Cells for Hazard Assessment
Published on: May 6, 2020
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Hepatitis
Viral Hepatitis I: Introduction